Analab Clinical Research
first-in-man,clinical Trial Site, Clinical Research, Kansas city, Clinical Study, Clinical Trial, Phase I-II, Phase I, CRO, early phase development, biopharmaceuticals, research facility, clinical conduct, clinical protocol, Analab Clinical Research, Kans